about
A Novel Gd-DTPA-conjugated Poly(L-γ-glutamyl-glutamine)-paclitaxel Polymeric Delivery System for Tumor Theranostics.Identification of motor neurons and a mechanosensitive sensory neuron in the defecation circuitry of Drosophila larvae.Tumor-penetrating peptide mediation: an effective strategy for improving the transport of liposomes in tumor tissue.Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.Dosage Form Developments of Nanosuspension Drug Delivery System for Oral Administration Route.Strategies of overcoming the physiological barriers for tumor-targeted nano-sized drug delivery systems.Poly (l-γ-glutamylglutamine) Polymer Enhances Doxorubicin Accumulation in Multidrug Resistant Breast Cancer Cells.RGD-modified lipid disks as drug carriers for tumor targeted drug delivery.MPEG-DSPE polymeric micelle for translymphatic chemotherapy of lymph node metastasis.Investigation of the roles of exosomes in colorectal cancer liver metastasis.Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex.The use of myristic acid as a ligand of polyethylenimine/DNA nanoparticles for targeted gene therapy of glioblastoma.LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor.Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemiaMultifunctional targeted liposomal drug delivery for efficient glioblastoma treatmentSelf-assembly of regenerated silk fibroin from random coil nanostructures to antiparallel β-sheet nanostructures.Tip-induced micropatterning of silk fibroin protein using in situ solution atomic force microscopy.Long-Circulating Liposomal Delivery System Targeting at PDGFR-β Enhances the Therapeutic Effect of IFN-α on Hepatic Fibrosis.Loop 2 of Ophiophagus hannah toxin b binds with neuronal nicotinic acetylcholine receptors and enhances intracranial drug delivery.Retro-inverso CendR peptide-mediated polyethyleneimine for intracranial glioblastoma-targeting gene therapy.pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis.The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells.Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.Synthesis and biological evaluation of an anticancer drug delivery system: Poly(l-γ-glutamyl-l-carbocisteine)-paclitaxel nanoconjugate.Erythrocyte Membrane-Wrapped pH Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy.An effective intracellular delivery system of monoclonal antibody for treatment of tumors: erythrocyte membrane-coated self-associated antibody nanoparticles.iNGR-Modified Liposomes for Tumor Vascular Targeting and Tumor Tissue Penetrating Delivery in the Treatment of Glioblastoma.Stabilized Heptapeptide A7R for Enhanced Multifunctional Liposome-Based Tumor-Targeted Drug Delivery.Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes.Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-beta-cyclodextrinRoles of dextrans on improving lymphatic drainage for liposomal drug delivery systemOdorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administrationThe Application of Nanotechnology in the Codelivery of Active Constituents of Plants and Chemotherapeutics for Overcoming Physiological Barriers during Antitumor TreatmentLiver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities
P50
Q33812462-A780A2E1-4F1A-4C66-9832-73F76BC70499Q34573841-5D950724-361B-4B52-BC7E-62ADF80BF72BQ35064480-CDF1A45B-74B9-49B4-85AA-7C1726B8F419Q38289727-221CD54B-843F-474D-BA15-B405AA97A5DBQ38577359-10FC1CB8-A846-4E37-ADBA-CEAF1043C499Q38616703-D5756F07-B2E5-410E-9269-A5CDC4BCE2B1Q38766094-A40486A1-3663-4EDF-B329-D3F0DB786228Q38786704-23EDA6FC-BDAE-439A-B9CE-727195AF3587Q38891056-F804DE54-D7CD-4C69-A181-E1F6DF4A8166Q38901222-E2856A5C-887A-4B37-9244-B2BB62A4AAF7Q39075507-6C945CEE-CF73-46DA-9230-B557D69F4086Q39466558-483D2593-A3CC-40B5-8F73-38E5BD1D8731Q39492815-B7DBA3E6-049B-4D1B-992F-6F085BCFFDFFQ41558781-0969E6A4-88AB-4DC4-B3BD-05DB3F976AFEQ41845603-0E832334-1172-4E6B-B5A9-C15140A9E710Q42002242-5279140B-B301-4674-8C09-CB57E2EA101BQ42010208-FA9B82A8-C906-4230-8D43-CA34621538B8Q42804896-0F9C79A2-9EAA-48D1-A057-697F51CBCDCAQ42851771-2107DA64-BB99-4DA7-8867-F76EB0DE01CDQ45862246-C43C986F-7894-452B-9A7D-65081B79161BQ45874605-BD4CD7CB-6732-40F5-8681-E435D933146DQ46953772-D8CF864C-E900-4E23-9A41-71B0FDFF5888Q47610958-DB6CE86F-FBA7-4062-84F7-F7E732C25967Q47695640-35D37D04-D2DB-44B1-A78B-97E1D44611B7Q47715879-061BF069-F77B-42CE-B56B-56B5794BB548Q47978724-29AA0CC8-6977-4EE6-A05F-0D75EA109B47Q48304816-265E5BCE-5CD6-40AA-AB27-E255D74E9C11Q48725267-D154E046-5762-4D6B-9CA5-E4FF409C18FEQ49040652-0052AA9A-15CA-4CBA-B961-9619BEA88DCDQ50740770-7B369E11-70D7-4FF9-8ADF-18E82B373378Q81494106-1F3AFDEF-3611-4C25-AC2C-714B2F2097E7Q82803969-00361E45-9326-46A8-A7A6-44D326EEBCB2Q83505522-EB6786DC-9B70-4EA4-934E-D39111746BA7Q92505729-28B80F4D-F025-46BC-BEC3-B8FBBB60FE7AQ94603124-50A762BF-84E3-4894-9CDF-283113402D7C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Zhiqiang Yan
@ast
Zhiqiang Yan
@en
Zhiqiang Yan
@es
Zhiqiang Yan
@sl
type
label
Zhiqiang Yan
@ast
Zhiqiang Yan
@en
Zhiqiang Yan
@es
Zhiqiang Yan
@sl
prefLabel
Zhiqiang Yan
@ast
Zhiqiang Yan
@en
Zhiqiang Yan
@es
Zhiqiang Yan
@sl
P1053
P-9909-2017
P106
P31
P3829
P496
0000-0002-3176-5757